Duvall Diantha 4
4 · GENOCEA BIOSCIENCES, INC. · Filed Mar 7, 2019
Insider Transaction Report
Form 4
Duvall Diantha
CHIEF FINANCIAL OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2019-03-05+475,000→ 475,000 totalExercise: $0.83Exp: 2029-03-05→ Common Stock (475,000 underlying)
Footnotes (1)
- [F1]The Stock Option shall become exercisable as to 1/4th of the shares subject to the option on the first anniversary of the Grant Date and thereafter as to 1/36th of the shares on each subsequent monthly anniversary of the Grant Date (rounded down to the nearest whole share, except for the final vesting period, with respect to which all remaining shares will vest)